Hepatitis B Surface Antigen Seroprevalence among Prevaccine and Vaccine Era Children in Bangladesh
Authors:
- Repon C. PaulRPRepon C. Paul
- Mahmudur RahmanMRMahmudur Rahman
- Eric WiesenEWEric Wiesen
- Minal PatelMPMinal Patel
- Kajal C. BanikKBKajal C. Banik
- Ahmad R. SharifASAhmad R. Sharif
- Sharmin SultanaSSSharmin Sultana
- Mizanur RahmanMRMizanur Rahman
- Jayantha LiyanageJLJayantha Liyanage
- Nihal AbeysingheNANihal Abeysinghe
- Saleem KamiliSKSaleem Kamili
- Trudy MurphyTMTrudy Murphy
Open Access
- 5 September 2018
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 99 (3) , 764-771
Abstract
Bangladesh introduced hepatitis B vaccine in a phased manner during 2003–2005 into the routine childhood vaccination schedule. This study was designed to evaluate the impact of the introduction of hepatitis B vaccine in Bangladesh by comparing hepatitis B surface antigen (HBsAg) prevalence among children born before and after vaccine introduction and to estimate the risk of vertical transmission of chronic hepatitis B virus (HBV) infection from mother to infant. We also evaluated the field sensitivity and specificity of an HBsAg point-of-care test strip. We selected a nationally representative sample of 2,100 prevaccine era and 2,100 vaccine era children. We collected a 5-mL blood sample from each child. One drop of blood was used to perform rapid HBsAg testing. If a child had a positive HBsAg test result with the rapid test, a blood sample was collected from the mother of the HBsAg-positive child and from the mothers of two subsequently enrolled HBsAg-negative children. All samples were tested for serologic markers of HBV infection using standard enzyme-linked immunosorbent assay. One (0.05%) child in the vaccine era group and 27 (1.2%; 95% confidence interval [CI]: 0.8–1.7%) children in the prevaccine era group were HBsAg positive. Mothers of HBsAg-positive children were more likely to be HBsAg positive than mothers of HBsAg-negative children (odds ratios = 4.7; 95% CI: 1.0–21.7%). Sensitivity of the HBsAg rapid test was 91.2% (95% CI: 76.6–98.1%) and specificity was 100% (95% CI: 99.9–100%). The study results suggest that even without a birth dose, the hepatitis B vaccine program in Bangladesh was highly effective in preventing chronic HBV infection among children.Keywords
This publication has 32 references indexed in Scilit:
- Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural TanzaniaPLOS ONE, 2013
- A comprehensive situation assessment of injection practices in primary health care hospitals in BangladeshBMC Public Health, 2011
- Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity regionJournal of Viral Hepatitis, 2011
- The development of instruments to measure the work disability assessment behaviour of insurance physiciansBMC Public Health, 2011
- Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, BangladeshBMC Infectious Diseases, 2010
- Evaluation of a New Hepatitis B Virus Surface Antigen Rapid Test with Improved SensitivityJournal of Clinical Microbiology, 2008
- Bacteremic Typhoid Fever in Children in an Urban Slum, BangladeshEmerging Infectious Diseases, 2005
- Seroepidemiology of Hepatitis B and Delta Virus Infections in BangladeshJournal of Tropical Pediatrics, 2003
- Hepatitis B vaccine – do we need boosters?Journal of Viral Hepatitis, 2003
- Global programme for control of hepatitis B infectionVaccine, 1995